Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'addiction' OR with Authors including 'addiction' OR with Abstract including 'addiction' OR with Keywords including 'addiction'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
EDDY NB, HALBACH H, BRAEN... Synthetic substances with morphine-like effect: clinical experience; p... Bull World Health Or... 1957
Cohen S Lysergic acid diethylamide: side effects and complications J. Nerv. ment. Dis. 1960
Editorial Hallucinogenic drugs. The future Lancet 1961
Pichot P Hallucinogenic drugs. New Drugs Lancet 1961
Sercl M, Lovarik J, Jaros... Klinische Erfahrungen mit Psilocybin (CY 39 Sandoz) Psychiatria et Neuro... 1961
Haertzen CA, Hill HE, Bel... Development of the Addiction Research Center Inventory (ARCI): Selecti... Psychopharmacologia 1963
Hill HE, Haertzen CA, Wol... The Addiction Research Center Inventory: Appendix. I. Items comprising... Psychopharmacologia 1963
Hill HE, Haertzen CA, Wol... The addiction Research Center Inventory: Standardization of scales wh... Psychopharmacologia 1963
JA Schremly, P Solomon Drug Abuse and Addiction - Reporting in a General Hospital JAMA 1964
Haertzen CA On the Addiction Research Center Inventory Scores of Former Addicts Re... Psychol. Reports 1964
Haertzen CA Addiction Research Center Inventory (ARCI): Development of a General ... J. Nerv. Ment. Div. 1966
Haertzen CA Changes in correlation between responses to items of the Addiction Res... J of Psychopharmacol... 1966
Sandison RA The hallucinogenic drugs Practitioner 1968
Babaian EA Drug addiction control in the USSR Bull. Narcot. 1971
Savage C, McCabe OL (LSD) therapy of drug addiction. The drug abuse contr... 1972
Klerman GL Psychotropic hedonism vs pharmacological Calvinism Hastings Cent Rep 1972
Savage C, McCabe OL Residential psychedelic (LSD) therapy for the narcotic addict. A cont... Arch,Gen,Psychiat. 1973
Tarshis MS The LSD Controversy: an Overview Amer J Psychiat 1973
Remschmidt H Psychotische Zustandebilder bei jugendlichen Drogenkonsumenten Münch. med. Wschr. 1973
Toerien I Clotiapine in the management of alcoholism and drug addiction. Report ... Med. Proc. 1973
Janzik HH, Kroenert K, Gu... Hormonal Evaluation in Young Drug Addicts J.Pharmacol. 1974
Johnson BD Understanding British-addiction statistics Bulletin on Narcotic... 1975
Loo H, Caroli F La Conduite Toxicomaniaque dens ses Rapports a la Conduite Suicidaire Ann.Med.-Psychol 1975
Trube-Becker E Drogenabusus mit Todesfolge Med. Klin. 1975
McKerney JW Drug Effects and the Environmental Control of Behavior Pharmacol. Rev. 1975
Suwanlert S A study of kratom eaters in Thailand Bulletin on Narcotic... 1975
Stanton MD Drugs, Vietnam, and the Vietnam veteran: an overview Am J Drug Alcohol Ab... 1976
Bron B, Fröscher W, Gehle... Differentialdiagnostische und syndromgenetische Probleme und Aspekte d... Fortschr. Neurol. Ps... 1976
Jantz L Probleme und Möglochkeiten ambulanter und stationäer Behandlune von Su... Therapiewoche 1976
Ovcharov R, Bantoutova I,... Pharmacological Analysis of Certain Mecharisms of Morphine Addiction Acta Physiol.Pharmac... 1976
Bron B, Fröscher W, Gehle... Analyse chronischer psychotischer Zustandsbilder bei jugendlichen Drog... Fortschr. Neurol. Ps... 1977
Shaffer H Methadone and Pregnancy: Perspectives and Prescriptions J Psychedelic Drugs 1979
Jasinski DR Interdisciplinary Studies on Phencyclidine at the Addiction Research C... Psychopharmacol.Bull... 1980
Jaffe JH, Kanzler M, Gree... Abuse potential of loperamide Clin Pharmacol Ther 1980
Young RE, Milroy R, Hutch... The Rising Price Of Mushrooms The Lancet 1982
Gillman MA Nitrous oxide, an opioid addictive agent. Review of the evidence Am J Med 1986
Arnold WN Vincent van Gogh and the Thujone Connection JAMA 1988
Erickson PG, Murray GF Sex differences in cocaine use and experiences: a double standard revi... Am J Drug Alcohol Ab... 1989
Smith DE, Seymour RB LSD: History and Toxicity Psychiatric Annals 1994
Schifano F, Magni G MDMA ('ecstasy') abuse: psychopathological features and craving for ch... Biol Psychiatry 1994
Sarnyai Z, Kovacs GL Role of oxytocin in the neuroadaptation to drugs of abuse Psychoneuroendocrino... 1994
Gallimberti L, Schifano F... Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate ... Eur Arch Psychiatry ... 1994
Wolff K, Hay AW, Sherlock... Contents of 'ecstasy' Lancet 1995
Halpern JH The Use of Hallucinogens in the Treatment of Addiction Addiction Research 1996
Popik P Facilitation of memory retrieval by the 'anti-addictive' alkaloid, ibo... Life Sci 1996
Buttar HS, Moffatt JH, Fo... Developmental toxicity of 4-substituted amphetamines in mice Reprod Toxicol 1996
Gerada C, Ashworth M ABC of mental health. Addiction and dependence--I: Illicit drugs [publ... BMJ 1997
Davison D, Parrott AC Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and ... Human Psychopharmaco... 1997
Schwartz RH, Miller NS MDMA (ecstasy) and the rave: a review Pediatrics 1997
Ho BK What you need to know: addiction--Ecstasy Singapore Med J 1997
Lin LY, Di Stefano EW, Sc... Oxidation of Methamphetamine and Methylenedioxymethamphetamine by CYP2... Drug Metab Dispos 1997
Blackburn JR, Szumlinski ... Ibogaine effects on sweet preference and amphetamine induced locomotio... Behav Brain Res 1997
Schifano F, Di Furia L, F... MDMA ('ecstasy') consumption in the context of polydrug abuse: a repor... Drug Alcohol Depend 1998
Lerner AG Clonidine treatment for hallucinogen persisting perception disorder Am J Psychiatry 1998
Helsley S, Filipink RA, B... The effects of sigma, PCP, and opiate receptor ligands in rats trained... Pharmacol Biochem Be... 1998
Martellotta MC, Balducci ... Gamma-hydroxybutyric acid decreases intravenous cocaine self-administr... Pharmacol Biochem Be... 1998
Mash DC, Kovera CA, Buck ... Medication development of ibogaine as a pharmacotherapy for drug depen... Ann N Y Acad Sci 1998
Wollina U, Kammler HJ, He... Ecstasy pimples - a new facial dermatosis Dermatology 1998
Kovera CA, Kovera MB, Sin... Decreased Drug Craving During Inpatient Detoxification with Ibogaine Paper presented at t... 1998
Mash DC, Allen-Ferdinand ... [Ibogaine:] Clinical Observations of Safety after Single Oral Dose Adm... College on Problems ... 1998
Pablo J, Tyndale R, Obach... Pharmacokinetic Disposition of Ibogaine after Oral Administration to H... College on Problems ... 1998
Wickelgren I Teaching the brain to take drugs Science 1998
Sherlock K, Wolff K, Hay ... Analysis of illicit ecstasy tablets: implications for clinical managem... J Accid Emerg Med 1999
van de Wijngaart GF, Braa... Ecstasy use at large-scale dance events in the Netherlands. Journal of Drug Issu... 1999
Scearce-Levie K, Chen JP,... 5-HT receptor knockout mice: pharmacological tools or models of psychi... Ann N Y Acad Sci 1999
Alburges ME, Hanson GR Differential responses by neurotensin systems in extrapyramidal and li... Brain Res 1999
van Heijst A Ecstasy intoxication and gastric lavage J Toxicol Clin Toxic... 1999
Milgram NW, Callahan H, S... Adrafinil: A Novel Vigilance Promoting Agent CNS Drug Reviews 1999
Yensen R, Dryer D Addiction, Despair, and the Soul: Successful Psychedelic Psychotherapy... 1999
Schifano F Potential Human Neurotoxicity of MDMA (`Ecstasy'): Subjective Self-Rep... Neuropsychobiology 2000
Cami J, Farre M, et al Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): p... J Clin Psychopharmac... 2000
Erdtmann-Vourliotis M, Ma... Prior experience of morphine application alters the c-fos response to ... Brain Res Mol Brain ... 2000
Horan B, Gardner EL, Ashb... Enhancement of conditioned place preference response to cocaine in rat... Synapse 2000
Tagliaro F, Valentini R, ... Hair analysis by using radioimmunoassay, high-performance liquid chrom... Forensic Sci Int 2000
Jasinski DR An evaluation of the abuse potential of madafinil using methylphenidat... J Psychopharmacology 2000
Vastag B Pay Attention: Ritalin Acts Much Like Cocaine JAMA 2001
Sinclair JD Evidence about the use of naltrexone and for different ways of using i... Alcohol Alcohol 2001
Riba J, Rodri­guez-Fornel... Subjective effects and tolerability of the South American psychoactive... Psychopharmacology (... 2001
Riba J, Rodri­guez-Fornel... Psychometric assessment of the Hallucinogen Rating Scale Drug Alcohol Depend 2001
Taylor JR, Jentsch D Repeated intermittent administration of psychomotor stimulant drugs al... Bilogical Psychiatry 2001
Baumann MH, Pablo J, Ali ... Comparative neuropharmacology of ibogaine and its O-desmethyl metaboli... Alkaloids Chem Biol 2001
Alper KR Ibogaine: Review The Alkaloids 2001
Crockford R B.C.'s acid flashback Vancouver Sun 2001
Jenks CW Extraction studies of Tabernanthe iboga and Voacanga africana Nat Prod Lett 2002
Jenks CW Extraction studies of Tabernanthe iboga and Voacanga africana Nat Prod Lett 2002
Koesters SC, Rogers PD, R... MDMA ('ecstasy') and other 'club drugs'. The new epidemic Pediatr Clin North A... 2002
Ellison G Neural degeneration following chronic stimulant abuse reveals a weak l... Eur Neuropsychopharm... 2002
Massoud M, Jalilpour H, S... Toxicity of Peganum harmala: Review and a Case Report Iranian Journal Of P... 2002
Wachtel SR, ElSohly MA, R... Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol ... Psychopharmacology (... 2002
Dobkin de Rios M, Grob CS... Hallucinogens and redemption J Psychoactive Drugs 2002
Meyer A, Mayerhofer A, Ko... Rewarding effects of the optical isomers of 3,4-methylenedioxy-methyla... Neurosci Lett 2002
Krupitsky E, Burakov A, R... Ketamine psychotherapy for heroin addiction: immediate effects and two... J Subst Abuse Treat 2002
Lim DK Ketamine associated psychedelic effects and dependence Singapore Med J 2003
Lingford-Hughes A, Nutt D Neurobiology of addiction and implications for treatment Br J Psychiatry 2003
Kleiman MAR Costs and Benefits of Immunotherapies or Depot Medications for the Tre... Committee on Immunot... 2003
Schifano F, Leoni M, Mart... Importance of cyberspace for the assessment of the drug abuse market: ... Cyberpsychol Behav 2003
Vecellio M, Schopper C, M... Neuropsychiatric consequences (atypical psychosis and complex-partial ... J Psychopharmacol 2003
Salzmann J, Marie-Claire ... Importance of ERK activation in behavioral and biochemical effects ind... Br J Pharmacol 2003
Nichols DE Hallucinogens Pharmacology & Thera... 2004

Page 1 of 2   /   194 Entries Returned
2 next